Hangzhou Tigermed Consulting Co Ltd operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hangzhou Tigermed Consulting Co Ltd with three other
pharmaceutical manufacturers in Asia:
Prodia Widyahusada Tbk PT
sales of 1.36 trillion Indonesian Rupiahs [US$102.04 million]
Medical & Biological Laboratories Company Limited
(8.06 billion Japanese Yen [US$72.83 million]
of which 99%
was Reagent business), and
Dr. Lal PathLabs Ltd
based in India
(7.91 billion Indian Rupees [US$124.00 million]
of which 100%
Hangzhou Tigermed Consulting Co Ltd reported sales of 1.17 billion Chinese Renmimbi (US$183.40 million)
December of 2016.
increase of 22.7%
versus 2015, when the company's sales were 956.97 million Chinese Renmimbi.
Sales at Hangzhou Tigermed Consulting Co Ltd have increased during each of the previous five years
(and since 2011, sales have increased a total of 522%).